Consistent with the critical role of the TPO-MPL signaling axis in HSC maintenance and proliferation, loss-of-function (LOF) and gain-of-function (GOF) mutations in TPO and MPL have been identified as underlying multiple hematological disorders (Figure 1a, Table I) [77,92]. This evidence concerns the gene TPO and hematologic disorder.